Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q1 2022 · 10-Q
Revenue$3.32M$3.32M−79.7% vs Q1 2021 Net Income-$28.17M-$28.17MN/M vs Q1 2021 EPS Diluted-$0.46-$0.46N/M vs Q1 2021 Operating Income-$27,335,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
Free Cash Flowderived-$29,690,000N/M Margins · derivedOperating margin-824.1%−709.5 pt vs Q1 2021
Net margin-849.2%−734.9 pt vs Q1 2021
ended Mar 31, 2022 · filed May 9, 2022 · 39 d after period end